We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+5.89%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$53.6B
AUM Growth
+$2.66B
(+5.2%)
Cap. Flow
+$86.8M
Cap. Flow
% of AUM
0.16%
Top 10 Holdings %
Top 10 Hldgs %
37.17%
Holding
821
New
56
Increased
227
Reduced
258
Closed
253
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$86.2M |
| 2 |
Alcon
ALC
|
+$81.8M |
| 3 |
NVIDIA
NVDA
|
+$76M |
| 4 |
Corning
GLW
|
+$50.4M |
| 5 |
UnitedHealth
UNH
|
+$42.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$67.4M |
| 2 |
Factset
FDS
|
+$62M |
| 3 |
Euronet Worldwide
EEFT
|
+$42.3M |
| 4 |
Bank of America Series L
BAC.PRL
|
+$39.5M |
| 5 |
OPLN
Openlane
OPLN
|
+$31.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.75% |
| 2 | Consumer Discretionary | 17.74% |
| 3 | Financials | 11.65% |
| 4 | Healthcare | 11.2% |
| 5 | Communication Services | 10.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Paychex
PAYX
$42.7B
| $4.37M | 0.01% |
53,136
-12,987
| -20% | -$1.1M |
|
402
Prudential Financial
PRU
$41.8B
| $4.34M | 0.01% |
42,981
-5,101
| -11% | -$509K |
|
403
Altria Group
MO
$114B
| $4.32M | 0.01% |
91,223
-4,009
| -4% | -$210K |
|
404
AbbVie
ABBV
$435B
| $4.29M | 0.01% |
58,946
-5,699
| -9% | -$448K |
|
|
CHK
405
DELISTED
Chesapeake Energy Corporation
CHK
| $4.21M | 0.01% |
10,791
| – | – |
|
406
Darden Restaurants
DRI
$24.4B
| $4.2M | 0.01% |
34,479
+33,576
| +3,718% | +$4M |
|
407
Stewart Information Services
STC
$2.08B
| $4.19M | 0.01% |
103,532
-13,963
| -12% | -$593K |
|
408
Thermo Fisher Scientific
TMO
$220B
| $4.17M | 0.01% |
14,201
-3,388
| -19% | -$933K |
|
409
JPMorgan Chase
JPM
$950B
| $4.15M | 0.01% |
37,151
+11,476
| +45% | +$1.27M |
|
|
WBA
410
DELISTED
Walgreens Boots Alliance
WBA
| $4.13M | 0.01% |
75,594
-2,813
| -4% | -$150K |
|
411
Verizon
VZ
$196B
| $4.08M | 0.01% |
71,351
+19,901
| +39% | +$1.15M |
|
|
CJ
412
DELISTED
C&J Energy Services, Inc.
CJ
| $4.04M | 0.01% |
342,972
+90,141
| +36% | +$1.23M |
|
|
KE
413
Kimball Electronics
KE
$628M
| $3.97M | 0.01% |
244,553
+26,537
| +12% | +$412K |
|
414
Intuit
INTU
$89B
| $3.96M | 0.01% |
15,154
+5,425
| +56% | +$1.38M |
|
|
NBL
415
DELISTED
Noble Energy, Inc.
NBL
| $3.89M | 0.01% |
173,719
-17,102
| -9% | -$406K |
|
416
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$6.92B
| $3.85M | 0.01% |
35,343
-2,136
| -6% | -$230K |
|
417
iShares MSCI Pacific ex Japan ETF
EPP
$2.28B
| $3.84M | 0.01% |
81,298
+11,991
| +17% | +$555K |
|
418
CDW
CDW
$17B
| $3.82M | 0.01% |
34,440
-12,562
| -27% | -$1.32M |
|
419
Molson Coors Class B
TAP
$8.09B
| $3.73M | 0.01% |
66,700
-11,258
| -14% | -$657K |
|
420
Plains GP Holdings
PAGP
$4.9B
| $3.72M | 0.01% |
148,925
+33,471
| +29% | +$809K |
|
421
Sinclair Inc
SBGI
$1.03B
| $3.58M | 0.01% |
66,775
-7,757
| -10% | -$393K |
|
422
Apple
AAPL
$4.57T
| $3.47M | 0.01% |
70,164
-20,240
| -22% | -$986K |
|
423
Gaming and Leisure Properties
GLPI
$12.8B
| $3.45M | 0.01% |
88,436
+33,502
| +61% | +$1.33M |
|
424
Occidental Petroleum
OXY
$55.9B
| $3.36M | 0.01% |
+66,854
| New | +$3.76M |
|
425
The GEO Group
GEO
$4.04B
| $3.36M | 0.01% |
159,808
+138,575
| +653% | +$2.92M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2019 Portfolio in Review
As of Q2 2019, Loomis, Sayles & Company held 821 positions worth $53.6B, up 5.2% from $50.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Loomis, Sayles & Company's Q2 2019 filing shows 56 new, 227 increased, 258 reduced and 253 closed positions. Its largest new stake was Alcon: 1,393,674 shares worth $86.5M. The largest sale was Novartis, an estimated $67.4M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- Loomis, Sayles & Company's largest Q2 2019 buy was Alcon: 1,393,674 shares worth $86.5M.
- Loomis, Sayles & Company added most to Bristol-Myers Squibb in Q2 2019, an estimated $86.2M increase.
- Loomis, Sayles & Company's biggest Q2 2019 reduction was Novartis, cutting an estimated $67.4M.
- Loomis, Sayles & Company fully exited RingCentral in Q2 2019, selling an estimated $30.4M.
- Loomis, Sayles & Company's ten largest holdings make up 37% of its $53.6B portfolio in Q2 2019.
- Loomis, Sayles & Company opened 56 new positions and closed 253 in Q2 2019.
- Loomis, Sayles & Company's portfolio value rose 5.2% quarter-over-quarter to $53.6B.
Based on Loomis, Sayles & Company's 13F filing for Q2 2019, filed 14 Aug 2019.